Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- bs-2138R - Provider product page
- Provider
- Bioss
- Proper citation
- Bioss Cat#bs-2138R, RRID:AB_10855907
- Product name
- PARP1 Polyclonal Antibody
- Antibody type
- Polyclonal
- Description
- KLH conjugated synthetic peptide derived from human PARP1
- Reactivity
- Human, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100ul
- Concentration
- 1ug/ul
- Storage
- Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Store at -20°C for 12 months.
Submitted references Electroacupuncture promotes peripheral nerve regeneration after facial nerve crush injury and upregulates the expression of glial cell-derived neurotrophic factor.
MiR-199a-3p suppresses proliferation and invasion of prostate cancer cells by targeting Smad1.
Minocycline attenuates sevoflurane-induced cell injury via activation of Nrf2.
MicroRNA-140 Provides Robustness to the Regulation of Hypertrophic Chondrocyte Differentiation by the PTHrP-HDAC4 Pathway.
Up-regulation of neogenin-1 increases cell proliferation and motility in gastric cancer.
Fei J, Gao L, Li HH, Yuan QL, Li LJ
Neural regeneration research 2019 Apr;14(4):673-682
Neural regeneration research 2019 Apr;14(4):673-682
MiR-199a-3p suppresses proliferation and invasion of prostate cancer cells by targeting Smad1.
Qu F, Zheng J, Gan W, Lian H, He H, Li W, Yuan T, Yang Y, Li X, Ji C, Yan X, Xu L, Guo H
Oncotarget 2017 Aug 8;8(32):52465-52473
Oncotarget 2017 Aug 8;8(32):52465-52473
Minocycline attenuates sevoflurane-induced cell injury via activation of Nrf2.
Tian Y, Wu X, Guo S, Ma L, Huang W, Zhao X
International journal of molecular medicine 2017 Apr;39(4):869-878
International journal of molecular medicine 2017 Apr;39(4):869-878
MicroRNA-140 Provides Robustness to the Regulation of Hypertrophic Chondrocyte Differentiation by the PTHrP-HDAC4 Pathway.
Papaioannou G, Mirzamohammadi F, Lisse TS, Nishimori S, Wein MN, Kobayashi T
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2015 Jun;30(6):1044-52
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2015 Jun;30(6):1044-52
Up-regulation of neogenin-1 increases cell proliferation and motility in gastric cancer.
Kim SJ, Wang YG, Lee HW, Kang HG, La SH, Choi IJ, Irimura T, Ro JY, Bresalier RS, Chun KH
Oncotarget 2014 May 30;5(10):3386-98
Oncotarget 2014 May 30;5(10):3386-98
No comments: Submit comment
Supportive validation
- Submitted by
- Bioss (provider)
- Main image
- Experimental details
- Lane 1: human colon carcinoma lysates Lane 2: rat brain lysates probed with Anti PARP (N-Terminus) Polyclonal Antibody, Unconjugated (bs-2138R) at 1:200 in 4°C. Followed by conjugation to secondary antibody (bs-0295G-HRP) at 1:3000 90min in 37°C. Predicted band 112kD. Observed band size: 112kD.
- Sample type
- Rat
- Other comments
- Brain
Supportive validation
- Submitted by
- Bioss (provider)
- Main image
- Experimental details
- Formalin-fixed and paraffin embedded rat brain labeled with Anti PARP (N-Terminus) Polyclonal Antibody, Unconjugated(bs-2138R) at 1:200 followed by conjugation to the secondary antibody Goat Anti-Rabbit IgG, FITC conjugated(bs-0295G-FITC)used at 1:200 dilution for 40 minutes at 37°C and DAPI
- Sample type
- Rat
- Other comments
- Brain